Bone Tissue Engineering in the Treatment of Bone Defects

Nannan Xue, Xiaofeng Ding, Rizhong Huang, Ruihan Jiang, Heyan Huang, Xin Pan, Wen Min, Jun Chen, Jin‐Ao Duan, Pei Liu, Yiwei WangPharmaceuticals 2022 · DOI

TL;DR

Bone defects pose a significant clinical challenge, driving the need for advanced repair strategies. This review highlights the evolution of bone tissue engineering, from traditional grafts to cutting-edge 3D-printed scaffolds, emphasizing the critical role of biomaterials, scaffold design, and emerging technologies like exosomes and microneedles in achieving functional bone regeneration.

What Problem Does This Paper Address?

Bone defects, arising from trauma, infection, or disease, can lead to substantial damage, prolonged treatment, and impaired function. Current clinical treatments, including bone grafting and surgical techniques, have limitations, especially for large or complex defects. The aging population further exacerbates the demand for effective bone repair materials. This paper addresses the critical need for innovative solutions by reviewing the current landscape and future prospects of bone tissue engineering, focusing on the development of advanced scaffolds and therapeutic strategies for bone defect repair.

Methods

This review synthesizes existing research on bone tissue engineering. It covers:

  • Clinical Treatment Modalities: A discussion of current surgical interventions like bone grafting, the Masquelet technique, and the Ilizarov technique, alongside non-invasive therapies.
  • Biomaterial Characterization: An in-depth analysis of inorganic (metals, bioceramics), natural (collagen, chitosan), and synthetic (polymers) biomaterials used in scaffold fabrication, evaluating their advantages and disadvantages in terms of biocompatibility, biodegradability, mechanical strength, and osteoconductivity/osteoinductivity.
  • Scaffold Preparation Technologies: An overview of fabrication methods, including traditional techniques and advanced approaches like 3D printing (e.g., SLA, SLS, FDM, DIW) and electrospinning, focusing on their ability to create complex, patient-specific structures.
  • Emerging Therapeutic Modalities: Exploration of novel approaches such as exosomes, microneedles, and adjuvant therapies (physiotherapy) that leverage biological signaling and targeted delivery for enhanced bone regeneration.

Datasets

Not discussed in the paper. This is a review article, not an experimental study with specific datasets.

Key Insights and Ideas

  • The "Gold Standard" Has Limitations: While autologous bone grafting is considered the gold standard due to its osteoinductive and osteoconductive properties, it's not always feasible or ideal, especially for extensive defects or in elderly patients, due to donor site morbidity and limited availability.
  • Biomaterial Synergy is Key: No single biomaterial perfectly addresses all bone regeneration needs. Combining different materials (e.g., hydroxyapatite with collagen, or bioceramics with polymers) can leverage their complementary properties to create more effective scaffolds.
  • 3D Printing Revolutionizes Customization: 3D printing technology offers unprecedented control over scaffold architecture, allowing for the creation of patient-specific implants that precisely match bone defect geometry, potentially improving integration and reducing complications.
  • Beyond Structural Support: Biological Cues Matter: Modern bone tissue engineering increasingly focuses on incorporating biological signals (growth factors like BMP-2, exosomes) and cellular components to actively stimulate and guide the regenerative process, rather than just providing a passive scaffold.
  • Exosomes as Therapeutic Nanocarriers: Exosomes, naturally occurring extracellular vesicles, are emerging as promising therapeutic agents due to their ability to deliver bioactive molecules (miRNAs, proteins) and influence cell behavior, offering a cell-free approach to enhance bone regeneration.
  • Microneedles for Targeted Drug Delivery: Microneedle technology presents a minimally invasive method for delivering therapeutic agents (like bisphosphonates or parathyroid hormone) directly to bone tissue, improving bioavailability and patient compliance.

Key Results

This review doesn't present quantitative experimental results but rather synthesizes findings from numerous studies. Key qualitative findings include:

  • Scaffold Properties Dictate Outcomes: Pore size, porosity, surface chemistry, and mechanical properties of scaffolds significantly influence cell adhesion, proliferation, migration, and ultimately, bone regeneration. Optimal pore sizes are generally cited as being between 20-1500 µm, with pores ≥ 300 µm being critical for direct osteogenesis and vascularization.
  • 3D Printing Enables Complex Architectures: Advanced 3D printing techniques allow for the fabrication of intricate porous structures that mimic native bone, facilitating cell infiltration, nutrient transport, and tissue ingrowth.
  • Biomaterials Show Varied Efficacy: Hydroxyapatite and demineralized bone matrix are frequently used bone substitutes. However, challenges remain with integration, degradation rates, and mechanical properties for certain applications.
  • Emerging Therapies Show Promise: Studies on exosomes and microneedles demonstrate their potential to enhance osteogenesis, promote vascularization, and deliver therapeutic agents more effectively than conventional methods.

Limitations and Future Work

Limitations:

  • Vascularization: Achieving adequate vascularization within engineered bone constructs remains a significant challenge, as insufficient blood supply can lead to cell death and scaffold necrosis.
  • Biocompatibility and Biodegradability: While many materials are biocompatible, achieving the ideal balance of degradation rate that matches new bone formation is crucial. Some materials, like titanium alloys, have slow degradation, requiring secondary surgery.
  • Cellular Challenges: Issues like low abundance of stem cells, post-translational survival, and immunomodulatory challenges for certain cell types (e.g., BMSCs) need to be addressed.
  • Clinical Translation: Despite significant advancements, translating many promising in vitro and in vivo findings into successful clinical applications for complex bone defects is still a long-term goal.

Future Work:

  • Personalized Scaffolds: Further development of 3D printing and computational design to create highly personalized scaffolds that perfectly match individual bone defect geometries.
  • Smart Biomaterials: Designing "smart" scaffolds that can respond to physiological cues, release therapeutic agents in a controlled manner, and actively promote regeneration.
  • Combination Therapies: Integrating multiple therapeutic strategies (e.g., biomaterials, cells, growth factors, and physical stimulation) to achieve synergistic effects for complex bone defects.
  • Understanding Biological Mechanisms: Deeper investigation into the intricate biological mechanisms governing bone regeneration, particularly the roles of exosomes and other signaling pathways, to develop more targeted and effective therapies.
  • Improving Vascularization Strategies: Developing novel approaches to promote rapid and efficient vascularization within engineered bone constructs.

Summary updated

Abstract

Bones play an important role in maintaining exercise and protecting organs. Bone defect, as a common orthopedic disease in clinics, can cause tremendous damage with long treatment cycles. Therefore, the treatment of bone defect remains as one of the main challenges in clinical practice. Today, with increased incidence of bone disease in the aging population, demand for bone repair material is high. At present, the method of clinical treatment for bone defects including non-invasive therapy and invasive therapy. Surgical treatment is the most effective way to treat bone defects, such as using bone grafts, Masquelet technique, Ilizarov technique etc. In recent years, the rapid development of tissue engineering technology provides a new treatment strategy for bone repair. This review paper introduces the current situation and challenges of clinical treatment of bone defect repair in detail. The advantages and disadvantages of bone tissue engineering scaffolds are comprehensively discussed from the aspect of material, preparation technology, and function of bone tissue engineering scaffolds. This paper also summarizes the 3D printing technology based on computer technology, aiming at designing personalized artificial scaffolds that can accurately fit bone defects.
BibTeX
@inproceedings{xue2022bone,
  author = {Nannan Xue and Xiaofeng Ding and Rizhong Huang and Ruihan Jiang and Heyan Huang and Xin Pan and Wen Min and Jun Chen and Jin‐Ao Duan and Pei Liu and Yiwei Wang},
  title = {{Bone Tissue Engineering in the Treatment of Bone Defects}},
  booktitle = {Pharmaceuticals},
  year = {2022},
  doi = {10.3390/ph15070879},
}
Figure